Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Neoplasms 2Thyroid Cancer, Papillary 1Infertility 1Adenocarcinoma, Follicular 1

Interventions

Radiofrequency Ablation 2Interviews as Topic 2dabrafenib 1Thyroxine 1Thyroid (USP) 1Robotic Surgical Procedures 1Iodine-131 1Gefitinib 1Ferrosoferric Oxide 1Ethanol 1Digoxin 1Decision Support Techniques 1Counseling 1Conversion to Open Surgery 1Administration, Cutaneous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Thyroid Cancer, Papillary × Iodine-131 × Clear all
NCT04354324 2024-03-15

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

Zhujiang Hospital

Phase NA Unknown
254 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡